Kirsten Bibbins-Domingo, MD, PhD, MAS, still recalls the excitement she felt early in her career upon learning that her study had been accepted for publication in JAMA.
For the prospective cohort study about NT-proBNP testing and cardiovascular disease events, she remembers “the editor in charge of the paper at the time demanding quite a number of additional analyses and revisions, many more than the reviewers had actually asked for and—finally—saying to us, ‘It’s really important we get things right. Because when JAMA publishes something, it affects clinical practice.’”
Now Dr. Bibbins-Domingo, who has had dozens of articles published in JAMA Network journals and well over 300 altogether, will feel that special obligation on the other side of the desk in medical journalism. Starting July 1, the general internist, cardiovascular disease epidemiologist and national leader in the fields of disease prevention and health equity will become the editor-in-chief of JAMA and JAMA Network.
With each succeeding JAMA Network publication, Dr. Bibbins-Domingo has “seen firsthand how practice or policy has shifted as a result, not just because of the scientific finding, but because of its publication under the trusted name that JAMA represents,” she said during a news briefing this week. “It’s truly very special and I’m thrilled to now be part of it.”
My latest for the AMA. The whole shebang.